The impact of electrical charge on the viability and physiology of dendritic cells

Scandinavian Journal of Immunology

Volumn 62, Issue 4, 2005, Pages 399-406

  Hilpert, F ^a   Heiser, A ^a   Wieckhorst, W ^a   Arnold, N ^a   Kabelitz, D ^a   Jonat, W ^a   Pfisterer, J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; ELECTRIC FIELD; ELECTRICITY; ELECTROFUSION (CELL); ELECTROPORATION; ENDOCYTOSIS; EVALUATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENE AMPLIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STANDARDIZATION;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; DEXTRANS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; ENDOCYTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS;

EID: 27644573816     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01677.x     Document Type: Article

References (32)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
2. Mangeot PE, Duperrier K, Negrave;gre D et al. High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 2002;5:283-90.
3. Nair SK, Morse M, Boczkowski D et al. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg 2002;235:540-9.
4. Shibagaki N, Udey MC. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol 2002;168:2393-401.
5. Heiser A, Dahm P, Yancey DR et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 2000;164:5508-14.
6. Scott-Taylor TH, Pettengell R, Clarke I et al. Human tumor and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochim Biophys Acta 2000;1500:265-79.
7. Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
8. Hsu FJ, Benike C, Fagnoni F et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8.
9. Kwang-Woon K, Sun-Hee K, Jung-Hee J et al. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity. Cancer Immunol Immunother 2004;53:315-22.
10. Parkhurst MR, DePan C, Riley JP, Rosenberg SA, Shu S. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules. J Immunol 2003;170:5317-25.
11. Trefzer U, Weingart G, Chen Y et al. Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int J Cancer 2000;85:618-26.
12. Schag K, Schmidt SM, Muller MR et al. Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes. Clin Cancer Res 2004;10:3658-66.
13. Bonehill A, Heirman C, Tuyaerts S et al. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide. Cancer Res 2003;63:5587-94.
14. Van Tendeloo VFI, Ponsaerts P, Lardon F et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001;98:49-56.
15. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184:465-72.
16. Mu LJ, Gaudernack G, Saeboe-Larssen S, Hammerstad H, Tierens A, Kvalheim G. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines. Scand J Immunol 2003;58:578-86.
17. Teissié J, Ramos C. Correlation between electric field pulse induced long-lived permeabilization and fusogenicity in cell membranes. Biophys J 1998;74:1889-98.
18. Shimizu K, Kuriyama H, Kjaergaard J, Lee W, Tanaka H, Shu S. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy. J Immunother 2004;27:265-72.
19. Kjaergaard J, Shimizu K, Shu S. Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine. Cell Immunol 2003;225:65-74.
20. Orentas RJ, Schauer D, Bin Q, Johnson BD. Electrofusion of a weekly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine. Cell Immunol 2001;213:4-13.
21. Meldrum RA, Bowl M, Ong SB, Richardson S. Optimisation of electroporation for biochemical experiments in live cells. Biochem Biophys Res Comm 1999;256:235-9.
22. Meaking WS, Edgerton J, Wharton CW, Meldrum RA. Electroporation-induced damage in mammalian cell DNA. Biochim Biophys Acta 1995;1264:357-62.
23. Trefzer U, Weingart G, Chen Y et al. A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma. Adv Exp Med Biol 1998;451:519-25.
24. Lundqvist A, Noffz G, Pavlenko M et al. Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection. J Immunother 2002;25:445-54.
25. Feuerstein B, Berger TG, Maczek C et al. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 2000;245:15-29.
26. Neil GA, Zimmermann U. Electrofusion. Methods Enzymol 1993;220:174-96.
27. Michiels A, Tuyaerts S, Bonehill A et al. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines. Gene Ther 2005;12:772-82.
28. Trevor KT, Cover C, Ruiz YW et al. Generation of dendritic cell-tumor cell hybrids by electro fusion for clinical vaccine application. Cancer Immunol Immunother 2004;53:705-14.
29. Piñero J, López-Baena M, Ortiz T, Cortés F. Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells. Apoptosis 1997;2:330-6.
30. Hammill AK, Uhr JW, Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 1999;251:16-21.
31. Gottfried E, Krieg R, Eichelberg C, Andreesen R, Mackensen A, Krause SW. Characterization of cells prepared by dendritic cell-tumor cell fusion. Cancer Immun 2002;2:15.
32. Jantscheff P, Spagnoli G, Zajac P, Rochlitz CF. Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells. Cancer Immunol Immunother 2002;51:367-75.